# Long-Term Therapy With Ribavirin for Chronic Hepatitis C

> **NCT00001854** · PHASE4 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 50 (—)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00001854
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02-12
- **Primary completion:** 2007-10-10
- **Final completion:** 2008-01-15
- **Target enrollment:** 50 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001854, "Long-Term Therapy With Ribavirin for Chronic Hepatitis C". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00001854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*